340B Prescription Drug Program - Flaget Memorial Hospital
Flaget Memorial Hospital is part of CHI Saint Joseph Health. Flaget Memorial Hospital, located in Bardstown, KY, is a 52-bed facility in the Nelson County area that treats patients from Hardin, Marion, Washington, Spencer, Bullitt, and LaRue counties in addition to Nelson County. Flaget Memorial Hospital is an award winning facility that moved to its current location in 2005. Nationally recognized for orthopedic care, surgical care and inpatient satisfaction, Flaget Memorial Hospital is in a park like setting with all private rooms designed to promote a healing environment.
The 340B prescription drug program is a vital lifeline for safety-net providers, supporting vital health services in our communities. The program is narrowly tailored to reach only hospitals that provide a high level of services to low-income individuals or that serve isolated rural communities. We provide comprehensive medical services to all patients, including a full spectrum of inpatient services, surgical services, and outpatient services such as emergency Medicine, Cancer Care, and Infusion Services. The 340B Program has allowed Flaget Memorial Hospital to expand access to care, cover expensive copays, and provide expensive medications free of cost, while focusing on safe, cost-effective care that results in improved patient outcomes.
- Uncompensated Care: $6.4 million
- Community Benefit: $14.6 million
(charity care + uncompensated care + community programs)
Benefits of the 340B Program
- We provide $6.4 million dollars in uncompensated care per year. The savings we receive for 340B significantly helps us be able to offset some of the costs of providing care to uninsured or underinsured patients.
- 340B Savings: $4.3 million
- Approximate DHS percentage: 12%
Impact if the program is scaled back
- Flaget Memorial Hospital provides a plethora of community health improvement services which would be cut without 340B resources.
- Pharmacists working in ambulatory areas who are volatile for achieving improved patient outcomes and reducing readmission would be scaled back